The influence of HDBA organic complex with vitamin D and calcium on the effectiveness of medical rehabilitation of patients with osteoporosis


L. Marchenkova, MD; E. Rozhkova, Biol.D
National Medical Research Center for Rehabilitation and Balneology, Moscow

Objective. To study the effect of basic pathogenetic therapy of osteoporosis and nutritional support using HDBA organic complex with vitamin D and calcium on the effectiveness and duration of maintaining the effect of medical rehabilitation, bone mineral density and the incidence of falls in patients with osteoporosis. Material and methods. The study included 119 patients aged 50 to 80 years, admitted to the inpatient stage of medical rehabilitation and diagnosed with osteoporosis according to one of the three diagnostic criteria formulated in the clinical recommendations of the Russian Ministry of Health, which were randomized in 3 groups. Patients in group 1 (n=41) were prescribed pathogenetic antiresorptive therapy for osteoporosis (bisphosphonates or denosumab) for 12 months, depending on the severity and clinical features of osteoporosis, contraindications to various types of therapy and the patient’s preferences regarding the frequency and mode of administration of the drug for the treatment of osteoporosis, in combination with nutritional support of the dietary supplement Osteomed Forte, containing an organic HDBA complex with vitamin D and calcium. Patients in group 2 (n=39) were prescribed only nutritional support with the dietary supplement Osteomed Forte in the same dosage. Patients of the third group made up the comparison group (n=39), in which patients did not receive any interventions. A control examination was carried out after completion of the rehabilitation course – 20 days after inclusion in the study, as well as 6 and 12 months after the start of treatment. Results. Long-term nutritional support of patients with osteoporosis using HDBA organic complex with vitamin D and calcium helps maintain muscle strength values achieved during rehabilitation for up to 6 months, indicators of quality of life and balance for up to 12 months after completion of rehabilitation, as well as significant increase in bone mineral density after 12 months compared to the baseline: in combination with pathogenetic therapy for osteoporosis – by 4.2% in the spine, by 3.0% in the femoral neck and by 2.7% in the proximal femur, without antiresorptive therapy – by 1.8% in the spine. Conclusion. Nutritional support in the form of correction of dietary calcium deficiency and vitamin D deficiency and the prescription of pathogenetic therapy for osteoporosis should be a mandatory part of complex rehabilitation measures in patients with osteoporosis to increase bone mineral density, improve efficiency and long-term maintenance of the results of medical rehabilitation.

nutritional support
vitamin D
medical rehabilitation
muscle strength
quality of life
Osteomed Forte
organic HDBA complex
drone brood.

  1. Bailey R.L., Dodd K.W., Goldman J.A. et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010; 140 (4): 817–22. DOI: 10.3945/jn.109.118539
  2. Никитинская О.А., Торопцова Н.В. Социальная программа «Остеоскрининг Россия» в действии. Фарматека. 2012; 6: 90–3 [Nikitinskaya O.A., Toroptsova N.V. Social Program "Osteoscreening Russia" at work. Farmateka. 2012; 6: 90–3 (in Russ.)].
  3. Марченкова Л.А., Фесюн А.Д., Герасименко М.Ю. и др. Влияние приема биологически активной добавки к пище с кальцием и витаминами D3 и B6 на показатели кальциевого гомеостаза и частоту падений у проходящих медицинскую реабилитацию пациентов с высоким риском переломов. Вопросы питания. 2020; 89(5): 89–100 [Marchenkova L.A., Fesyun A.D., Gerasimenko M.Yu., et al. The effect of administration of dietary supplement with calcium and vitamins D3 and B6 on calcium homeostasis and falls incidence in patients with high fracture risk undergoing medical rehabilitation. Problems of Nutrition. 2020; 89 (5): 89–100. (in Russ.)]. DOI: 10.24411/0042-8833-2020-10069
  4. Beaudart C., Buckinx F., Rabenda V. et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014; 99 (11): 4336–45. DOI: 10.1210/jc.2014-1742
  5. Reid I.R., Bolland M.J. Controversies in medicine: The role of calcium and vitamin D supplements in adults. Med J Aust. 2019; 211 (10.): 468–73. DOI: 10.5694/mja2.50393
  6. Weaver C.M., Alexander, D.D., Boushey, C.J. et al. Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016; 27 (1): 367–76. DOI: 10.1007/s00198-015-3386-5
  7. Белая Ж.Е., Рожинская Л.Я., Гребенникова Т.А. и др. Краткое изложение проекта федеральных клинических рекомендаций по остеопорозу. Остеопороз и остеопатии. 2020; 23 (2): 4–21 [Belaya Zh.E., Rozhinskaya L.Y., Grebennikova T.A. et al. Summary of the draft federal clinical guidelines for osteoporosis. Osteoporosis and Bone Diseases. 2020; 23 (2): 4–21 (in Russ.)]. DOI: 10.14341/osteo12710
  8. Пономаренко Г.Н. Физическая и реабилитационная медицина. Национальное руководство. Под ред. Г.Н. Пономаренко. М.: ГЭОТАР-Медиа, 2017; 512 с. [Ponomarenko G.N. Physical and rehabilitation medicine. National guide. Edited by G.N. Ponomarenko. Moscow: GEOTAR-Media, 2017; 512 p. (in Russ.)].
  9. Lips P., Cooper C., Agnusdei D. et al. Quality of life in patients with vertebral fractures: validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporos Int. 1999; 10 (2): 150–60. DOI: 10.1007/s001980050210
  10. Pfeifer M., Begerow B., Minne H.W. Vitamin D and muscle function. Osteoporos Int. 2002; 13 (3): 187–94. DOI: 10.1007/s001980200012
  11. Verlaan S., Maier A.B., Bauer J.M. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults – The PROVIDE study. Clin Nutr. 2018; 37 (2): 551–7. DOI: 10.1016/j.clnu.2017.01.005
  12. Bruyère O., Cavalier E., Reginster J.Y. Vitamin D and osteosarcopenia: an update from epidemiological studies. Curr Opin Clin Nutr Metab Care. 2017; 20 (6): 498–503. DOI: 10.1097/MCO.0000000000000411
  13. Burton E., Lewin G., O’Connell H. et al. Falls prevention in community care: 10 years on. Clin Interv Aging. 2018; 13: 261–9. DOI: 10.2147/CIA.S153687
  14. Hill K.D., Suttanon P., Lin S.-I. et al. What works in falls prevention in Asia: a systematic review and meta-analysis of randomized controlled trials. BMC Geriatr. 2018; 18 (1): 3. DOI: 10.1186/s12877-017-0683-1
  15. Morris ME. Preventing falls in older people. BMJ. 2012; 345: e4919. DOI: 10.1136/bmj.e4919
  16. Uusi-Rasi K., Kannus P., Karinkanta S. Study protocol for prevention of falls: A randomized controlled trial of effects of vitamin D and exercise on falls prevention. BMC Geriatr. 2012; 12: 12. DOI: 10.1186/1471-2318-12-12
  17. Mori T., Crandall C.J., Ganz D.A. Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA. Osteoporos Int. 2017; 28 (2): 585–95. DOI: 10.1007/s00198-016-3772-7
  18. Loprinzi P.D., Loenneke J.P., Blackburn E.H. Movement-based behaviors and leukocyte telomere length among US adults. Med Sci Sports Exerc. 2015; 47 (11): 2347–52. DOI: 10.1249/MSS.0000000000000695
  19. Скрипникова И.А., Мягкова М.А., Шальнова С.А. и др. Оценка абсолютного риска переломов среди городского и сельского населения в четырех регионах Российской Федерации. Профилактическая медицина. 2020; 23 (5): 33–9 [Skripnikova I.A., Myagkova M.A., Shalnova S.A. et al. Assessment of the absolute risk of fractures among urban and rural populations in 4 regions of the Russian Federation. Profilakticheskaya Meditsina. 2020; 23 (5): 33–9 (in Russ.)]. DOI: 10.17116/profmed20202305133
  20. Sanders K.M., Stuart A.L., Williamson E.J. et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010; 303 (18): 1815–22. DOI: 10.1001/jama.2010.594
  21. Лубенец А. Лечение повреждений проксимального отдела бедренной кости у больных старшей возрастной группы. Врач. 2017; 28 (7): 64–7 [Lubenets A. Treatment of proximal femur injuries in older age group patients. Vrach. 2017; 28 (7): 64–7 (in Russ.)].
  22. Кокорева И.Г., Кореньков А., Соловьев И. Влияние препарата Остеомеда Форте на сроки консолидации переломов костей у детей и подростков. Врач. 2020; 31 (1): 82–5 [Kokoreva I., Korenkov A., Solovyev I. Effect of Osteomed Forte on the terms of bone fracture consolidation in children and adolescents. Vrach. 2020; 31 (1): 82–5 (in Russ.)]. DOI: 10.29296/25877305-2020-01-18
  23. Эседова А., Идрисова М. Коррекция костно-метаболических нарушений в постменопаузе на фоне тиреоидной патологии. Врач. 2017; 28 (9): 41–6 [Esedova A., Idrisova M. Postmenopausal correction of bone metabolic disorders in the presence of thyroid diseases. Vrach. 2017; 28 (9): 41–6 (in Russ.)].
  24. Пешехонова Л.К., Пешехонов Д.В., Красюков П.А. Клиническая эффективность применения препаратов Остеомед, Остеомед Форте, Остео-Вит D3 у больных вторичным остеопорозом при ревматоидном артрите. Врач. 2020; 31 (4): 68–74 [Peshekhonova L., Peshekhonov D., Krasyukov P. The clinical efficiency of using Osteomed, Osteomed Forte, and Osteo-Vit D3 in patients with secondary osteoporosis in rheumatoid arthritis. Vrach. 2020; 31 (4): 68–74 (in Russ.)]. DOI: 10.29296/25877305-2020-04-12
  25. Струков В.И., Елистратов Д., Кислов А. и др. Новый подход в лечении пресенильного и сенильного остеопороза. Врач. 2013; 24 (10): 39–41 [Strukov V., Elistratov D., Kislov A. et al. New approach in presenilnogo's treatment and senile osteoporosis. Vrach. 2013; 24 (10): 39–41 (in Russ.)].
  26. Животощук В., Струков В., Ковалев А. Как повысить эффективность лечения деформирующего остеоартроза пальцев кистей и стоп у пожилых пациентов. Врач. 2014; 25 (10): 49–50 [Zhlvotoshchuk V., Strukov V., Kovalev A. How to enhance the effiiency of treatment for osteoarthrosis deformans of the fingers and toes in elderly patients. Vrach. 2014; 25 (10): 49–50 (in Russ.)].
  27. Струков В.И., Виноградова О.П., Сергеева-Кондраченко М.Ю. и др. Иммунотерапия постменопаузального остеопороза и других заболеваний костно-суставной системы на фоне гормональной недостаточности. Акушерство и гинекология: новости, мнения, обучение. 2022; 10 (2): 47–55 [Strukov V.I., Vinogradova O.P., Sergeeva-Kondrachenko M.Yu. et al. Immunotherapy of postmenopausal osteoporosis and other osteoarticular diseases against the background of hormonal deficiency. Obstetrics and Gynecology: News, Opinions, Training. 2022; 10 (1): 47–55 (in Russ.)]. DOI: 10.33029/2303-9698-2022-10-2-47-55